Prostate Cancer

Every Other Day or Once a Week: Long-term Oncological Outcomes in the Phase 2 PATRIOT Trial of Prostate Stereotactic Ablative Body Radiotherapy. April 29, 2025

Optimizing biopsy decisions in PI-RADS 3 lesions: cross-institutional validation of a local clinical risk model. April 29, 2025

Trends in Surgical Overtreatment of Prostate Cancer. April 29, 2025

Cost-effectiveness of serum, urine, and tissue-based prostate cancer biomarkers. April 29, 2025

Salvage Radiosurgery After Brachytherapy for Locally Recurrent Prostate Cancer With Real-Time Adaptive Motion Management Using Previously Implanted Brachytherapy Seeds as Fiducial Markers. April 29, 2025

Optimizing therapy for high-risk biochemically recurrent non-metastatic prostate cancer: Current and emerging strategies. April 28, 2025

Individuals from culturally and linguistically diverse backgrounds have more advanced prostate cancer at diagnosis in Victoria, Australia. April 28, 2025

Long-term outcomes of radiotherapy and impact of nodal disease burden in clinically node-positive prostate cancer. April 28, 2025

Combination metastasis-targeted external beam radiation therapy with 177Lu-PSMA-617 in patients with advanced castration-resistant prostate cancer. April 28, 2025

Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data. April 28, 2025

Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancer. April 28, 2025

Sexual activity in men undergoing ADT for localized prostate cancer: a narrative literature review. April 28, 2025

AUA 2025: Testosterone Recovery Following Treatment Suspension of Enzalutamide plus Leuprolide or Leuprolide Alone in Patients with High-Risk Biochemically Recurrent Prostate Cancer: EMBARK Post Hoc Analysis April 27, 2025

Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer. April 25, 2025

Preservation of Neurovascular Bundles in High-risk Prostate Cancer Patients: Long-term Oncological Outcomes from Two High-volume Tertiary Centers. April 25, 2025

Prostate-specific membrane antigen positron-emission tomography for novel risk-stratification of biochemical recurrence. April 25, 2025

Evaluation of 3D ARFI imaging of prostate cancer: diagnostic reliability and concordance with MpMRI. April 25, 2025

The prognostic role of prostate MRI in prostate cancer patients. April 25, 2025

Evolution of Active Surveillance of Prostate Cancer: Impact of MRI, MRI-guided Biopsy and Focal Therapy. April 24, 2025

Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial. April 24, 2025

Page 1 of 1474